Dijkstra, J., van Altena, R., Akkerman, O., de Lange, W., Proost, J., van der Werf, T., . . . Alffenaar, J. (2015). Limited sampling strategies for therapeutic drug monitoring of amikacin and kanamycin in patients with multidrug-resistant tuberculosis. International journal of antimicrobial agents, 46(3), 332-337. https://doi.org/10.1016/j.ijantimicag.2015.06.008
Citace podle Chicago (17th ed.)Dijkstra, J.A, R. van Altena, O.W Akkerman, W.C.M de Lange, J.H Proost, T.S van der Werf, J.G.W Kosterink, a J.W.C Alffenaar. "Limited Sampling Strategies for Therapeutic Drug Monitoring of Amikacin and Kanamycin in Patients with Multidrug-resistant Tuberculosis." International Journal of Antimicrobial Agents 46, no. 3 (2015): 332-337. https://doi.org/10.1016/j.ijantimicag.2015.06.008.
Citace podle MLA (9th ed.)Dijkstra, J.A, et al. "Limited Sampling Strategies for Therapeutic Drug Monitoring of Amikacin and Kanamycin in Patients with Multidrug-resistant Tuberculosis." International Journal of Antimicrobial Agents, vol. 46, no. 3, 2015, pp. 332-337, https://doi.org/10.1016/j.ijantimicag.2015.06.008.